Severe acute respiratory syndrome (SARS): A year in review

被引:116
作者
Skowronski, DA [1 ]
Astell, C
Brunham, RC
Low, DE
Petric, M
Roper, RL
Talbot, PJ
Tam, T
Babiuk, L
机构
[1] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada
[2] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada
[3] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[4] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC 27858 USA
[5] Inst Armand Frappier, INRS, Lab Neuroimmunovirol, Laval, PQ H7V 1B7, Canada
[6] Hlth Canada, Immunizat & Resp Infect Div, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada
[7] Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
来源
ANNUAL REVIEW OF MEDICINE | 2005年 / 56卷
关键词
emerging pathogen; pandemic; coronavirus; zoonotic; genomics;
D O I
10.1146/annurev.med.56.091103.134135
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.
引用
收藏
页码:357 / 381
页数:25
相关论文
共 102 条
  • [91] Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
    Wong, RSM
    Wu, A
    To, KF
    Lee, N
    Lam, CWK
    Wong, CK
    Chan, PKS
    Ng, MHL
    Yu, LM
    Hui, DS
    Tam, JS
    Cheng, G
    Sung, JJY
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7403): : 1358 - 1362
  • [92] Cluster of SARS among medical students exposed to single patient, Hong Kong
    Wong, TW
    Lee, CK
    Tam, W
    Lau, JTF
    Yu, TS
    Lui, SF
    Chan, PKS
    Li, YG
    Bresee, JS
    Sung, JJY
    Parashar, UD
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (02) : 269 - 276
  • [93] Word Health Organization, 2003, CAS DEF SURV SEV AC
  • [94] World Health Organization, 2003, EB113/33
  • [95] World Health Organization, 2004, SIT UPD SARS
  • [96] Wu HS, 2004, EMERG INFECT DIS, V10, P304
  • [97] Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus
    Yam, WC
    Chan, KH
    Poon, LLM
    Guan, Y
    Yuen, KY
    Seto, WH
    Peiris, JSM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) : 4521 - 4524
  • [98] A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
    Yang, ZY
    Kong, WP
    Huang, Y
    Roberts, A
    Murphy, BR
    Subbarao, K
    Nabel, GJ
    [J]. NATURE, 2004, 428 (6982) : 561 - 564
  • [99] Evidence of airborne transmission of the severe acute respiratory syndrome virus
    Yu, ITS
    Li, YG
    Wong, TW
    Tam, W
    Chan, AT
    Lee, JHW
    Leung, DYC
    Ho, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (17) : 1731 - 1739
  • [100] Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
    Zhao, Z
    Zhang, F
    Xu, M
    Huang, K
    Zhong, W
    Cai, W
    Yin, Z
    Huang, S
    Deng, Z
    Wei, M
    Xiong, J
    Hawkey, PM
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (08) : 715 - 720